Chewing gum rapid test for inflammation

Chewing gum to screen for oral inflammation

17-Aug-2017

Uni Würzburg

Researchers from the University of Würzburg are working on a chewing gum that is capable of detecting oral inflammation.

Dental implants occasionally entail complications: Six to fifteen percent of patients develop an inflammatory response in the years after receiving a dental implant. This is caused by bacteria destroying the soft tissue and the bone around the implant in the worst case.

In future, patients will benefit from a quick and affordable method assessing whether they carry such bacteria: using a chewing gum based diagnostic test developed by a pharmaceutical research team at the Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany.

In practice, the test works as follows: If there is an inflammation in the oral cavity, a bittering agent is released while chewing the gum. Patients can then visit their dentist who confirms the diagnosis and treats the disease. This type of early detection aims at preventing serious complications such as bone loss.

"Anyone can use this new diagnostic tool anywhere and anytime without any technical equipment," Professor Lorenz Meinel says; he is the head of the JMU Chair for Drug Formulation and Delivery. He developed the new diagnostic tool with Dr. Jennifer Ritzer and her team; the invention is currently featured in an article in the journal "Nature Communication".

Enzymes release bitter taste

The scientific background: In the presence of inflammatory conditions, specific protein-degrading enzymes are activated in the mouth. In just five minutes, these enzymes also break down a special ingredient of the chewing gum, thereby releasing a bittering agent that could not be tasted before.

Meinel's team provided the proof that this principle actually works. First studies using the saliva of patients were conducted at Merli Dental Clinic in Rimini.

Company establishment planned

To launch the chewing gum into the market, Meinel's team plans to set up a company. The professor assumes that it will take two to three years until the gum is commercially available.

Chewing gum rapid tests for other medical applications are presently under development. "We hope to be able to diagnose other diseases with our “anyone, anywhere, anytime” diagnostics to identify and adress these diseases as early as possible," Meinel explains.

Julius-Maximilians-Universität Würzburg

Request information now

Recommend news PDF version / Print

Share on

Facts, background information, dossiers
  • chewing gum
  • inflammation
  • diagnostics
  • rapid tests
More about Uni Würzburg
  • News

    How receptors for medicines work inside cells

    G protein-coupled receptors are the key target of a large number of drugs. Würzburg scientists have now been able to show more precisely how these receptors act in the cell interior. The human genome encodes hundreds of G protein-coupled receptors (GPCRs). These form the largest group of r ... more

    Cancer detection with sugar molecules

    Scientists from the University of Würzburg have synthesized a complex sugar molecule which specifically binds to the tumor protein Galectin-1. This could help to recognize tumors at an early stage and to combat them in a targeted manner. Galectins are a family of proteins that have become ... more

    Ubiquitous and influential

    Scientists at the University of Würzburg have generated new insights into the intricate molecular underpinnings of ubiquitin signaling. Their results may provide new avenues for cancer therapy. The small protein ubiquitin regulates a plethora of physiological and pathophysiological process ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE